Clinical Trials Directory

Trials / Completed

CompletedNCT02252302

Exercise in Air Pollution and Lung Health in Asthmatics

The Effects of Inhaled Beta-2-Agonists and Air Pollution on Lung Function and Athletic Capacity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
19 Years – 40 Years
Healthy volunteers
Accepted

Summary

When exposed to air pollution, the asthma symptoms are aggravated and lung function is impaired. Due to high breathing rates and volumes, physically active individuals are at particular risk of lung health impairment due to the high breathing rates and volumes. Greater doses of air pollutants reach deeper areas in the lungs where they can trigger asthma-symptoms. When treating these symptoms with inhaled beta-2-agonists the airways widen even more, allowing the air pollutants to reach even deeper areas of the lung. With this study the investigators investigate how inhaled beta-2-agonists affect athletic capacity and lung health in physically active asthmatics.

Conditions

Interventions

TypeNameDescription
OTHERRest (Sitting on chair)Study participants will sit on a chair for 60min. This is to simulate physical resting condition.
OTHERCycling exerciseStudy participants will exercise on a cycle ergometer for 45min. Participants will start their 30-min long constant workload exercise test test 60-min after the drug intervention. The exercise test will be set to a resistance of 50% of the maximal wattage that was reached on the graded exercise test on the screening day. The cycling exercise intervention will follow the rest-intervention.
DRUGSalbutamol inhalationStudy participants will be exposed to 400ug of salbutamol prior to entering the air pollution chamber.
DRUGPlacebo inhalationStudy participants will inhale a placebo (placebo for salbutamol) prior to entering the air pollution chamber
OTHERDiesel Exhaust ExposureParticipants will be exposed to PM2.5 of 300 μg/m3
OTHERFiltered airParticipants will be breathing filtered air

Timeline

Start date
2015-05-01
Primary completion
2016-08-01
Completion
2021-05-01
First posted
2014-09-30
Last updated
2021-09-30

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02252302. Inclusion in this directory is not an endorsement.